| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8227105 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Survival for patients with pancreatic cancer remains poor. A small percentage of adjuvant patients have durable disease control, and with improved therapies, this proportion will increase. Systemic therapy offers the greatest opportunity. The present results have demonstrated that IMRT is well tolerated. Compared with those who received three-dimensional conformal radiotherapy in previously reported prospective clinical trials, patients with pancreatic adenocarcinoma treated with IMRT in our series had improved acute toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jonathan A. M.D., James D. M.D., M.S., Ann Yuriko M.D., M.S., Melody B.S., George A. M.D., Ph.D., James M. M.D., Ph.D., Pamela M.D., Jeffrey A. M.D., Brendan C. M.D., George A. M.D., Albert C. M.D., Ph.D., Daniel T. M.D.,